Aging Pilot Core
老化试点核心
基本信息
- 批准号:10274454
- 负责人:
- 金额:$ 91.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAddressAgingAreaArtificial IntelligenceCaregiversCaringChronic DiseaseCollaborationsCommunitiesDataData SourcesDatabasesDecision MakingEducational workshopElderlyEnsureEthicsFamily CaregiverFosteringFundingFutureGoalsHealthHealth Services AccessibilityHomeHome Care AgenciesHome Care ServicesImprove AccessIncomeIndustryInstitute of Medicine (U.S.)InstitutionInstitutionalizationInterventionLinkLow incomeMedicareMedicare/MedicaidMentorsMethodologyMinority GroupsNational Research CouncilNew YorkNursing HomesOlder PopulationOutcomePatientsPilot ProjectsPoliciesPolicy ResearchPopulationProfessional OrganizationsProviderQuality of lifeReportingRequest for ProposalsResearchResearch PersonnelRiskRuralScienceScientistSeriesServicesSiteTechnologyTestingTrainingValidationWorkaging in placebasecare outcomesclinical research siteclinical translationcollaboratorycommercializationcommunity based servicecomorbidityend of life carefederal poverty levelhealth care disparityhealth managementhealthy aginghuman capitalinnovationinterestmembernoveloutreachpatient orientedpeer networksperson centeredprogramssuccesssymposium
项目摘要
The Institute of Medicine and National Research Council workshop report on "The Future of Home Health Care”,
calls for care that is patient and person-centered, seamlessly connected and coordinated, high quality and
technology enabled. The overarching goal of the Aging Focus Pilot Core (Core G) is to promote the advancement
of science using technology and artificial intelligence to optimize health and care management for older adults
living in their homes independently, and those receiving skilled home and community-based services (H&CBS).
We capitalize on the opportunity to reach a national population receiving H&CBS which includes skilled home
health care (HHC), the Program for All-Inclusive Care for the Elderly (PACE), and Managed Long-Term Services
and Supports (MLTSS), in addition to healthy older adults living in the community. These populations of older
adults present an ideal opportunity to apply AI and technology to promote healthy aging and equitable access to
care and supports; address the needs of vulnerable older adults; avoid institutionalization; maintain quality of
life; and receive appropriate end-of-life care. We propose three aims: AIM 1. Establish a national network of
home care agencies, PACE sites, and MLTSS plans interested in supplying data and/or serving as test
sites for AI and technology solutions to support patients/members, providers, and family caregivers. The
Aim 1 outcome is a comprehensive national database of home care agencies, PACE sites, and MLTSS plans
interested in supplying data, serving as pilot test sites, or as purchasers of commercial products. The national
network of potential pilot sites and customers for commercial products developed through the Collaboratory will
grow each year through networks with our initial partners, contacts at national conferences, and outreach through
professional organizations. AIM 2. Foster collaborations among affiliated Penn investigators and our
network of peer institutions and research centers to grow a cadre of scientists to advance the science
of care within home and community-based services. The outcome of Aim 2 will be annual workshops that
build teams and educate investigators about the data sources, services, policies, and research questions
essential to promote the science of aging in place and bring products to market. AIM 3. Solicit, select,
develop/refine, and manage pilot studies that develop or test AI and technology applications to detect
risk, predict needs, address disparities, improve access to care, and support decision making for
chronic illness management and safe aging in place for older adults and their family caregivers.
Successful funding and completion of 2-3 funded pilot studies per year, dissemination of their results, and
commercialization of products brought to market that detect risk, predict needs, address disparities, improve
access to care, and support decision making for underserved and hard to reach older adults and their caregivers.
医学研究所和国家研究委员会关于“家庭保健的未来”的研讨会报告,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathryn Helene Bowles其他文献
Kathryn Helene Bowles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathryn Helene Bowles', 18)}}的其他基金
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10824878 - 财政年份:2023
- 资助金额:
$ 91.17万 - 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10527374 - 财政年份:2015
- 资助金额:
$ 91.17万 - 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10347321 - 财政年份:2015
- 资助金额:
$ 91.17万 - 项目类别:
Sepsis Survivors' Post-Acute Outcomes: Impact of Early Home Health and MD Visits
败血症幸存者的急性后结果:早期家庭健康和医学博士就诊的影响
- 批准号:
9007054 - 财政年份:2015
- 资助金额:
$ 91.17万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 91.17万 - 项目类别:
Research Grant